Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia

Publisher： Karger

E-ISSN： 2235-3186|130|4|229-238

ISSN： 1660-8151

Source： Nephron, Vol.130, Iss.4, 2015-07, pp. : 229-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 1, 2017-03 ,pp. : 33-42

Karger

Access to resources Recommend Favorite

Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia

By  

Blood Purification, Vol. 41, Iss. 4, 2015-12 ,pp. : 247-253

Karger

Access to resources Recommend Favorite

Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study

By  

American Journal of Nephrology, Vol. 45, Iss. 5, 2017-05 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

By  

American Journal of Nephrology, Vol. 44, Iss. 2, 2016-08 ,pp. : 150-158

Karger

Access to resources Recommend Favorite

A Pilot, Randomized, Double-Blind, Cross-Over Study of High Cut-Off versus High-Flux Dialysis Membranes

By  

Blood Purification, Vol. 28, Iss. 4, 2009-09 ,pp. : 365-372

Karger

Access to resources Recommend Favorite